Tolvaptan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1799 publications
Oral urea as a safety strategy in complex syndrome of inappropriate antidiuretic hormone secretion - Challenges posed by polypharmacy and institutionalization
Journal: Nutricion hospitalaria
Published: September 07, 2026
Chronic hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion in an elderly patient with chronic obstructive pulmonary disease: Favorable response to oral urea
Journal: Nutricion hospitalaria
Published: September 07, 2026
Urea vs. tolvaptan for hospitalized patients with SIADH.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 15, 2026
Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications.
Journal: Cells
Published: June 23, 2026
Autoimmune small-vessel cerebral vasculitis with refractory SIADH: clinical recovery after V2-receptor antagonism (tolvaptan).
Journal: BMJ case reports
Published: June 18, 2026
Efficacy and Safety of Combination Pharmacotherapies With Standard Diuretic Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis.
Journal: Cardiology in review
Published: June 17, 2026
Anti-Polyamine Therapy Restrains Kidney Cyst Growth in an Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Polyphenols and ADPKD: A Further Aid from Nature?
Journal: Life (Basel, Switzerland)
Published: May 20, 2026
Last Updated: 09/26/2026